Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-21-006587
Filing Date
2021-05-25
Accepted
2021-05-25 17:30:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 29060
2 filename2.txt TEXT-EXTRACT 3489
  Complete submission text file 0000000000-21-006587.txt   44150
Mailing Address 400 EAST JAMIE COURT SUITE 301 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 301 SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filed for) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations